Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C6H7N5O3 |
| Molecular Weight | 197.1515 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=N)N\N=C\C1=CC=C(O1)[N+]([O-])=O
InChI
InChIKey=ZGJOBTCQXNGPBN-YCRREMRBSA-N
InChI=1S/C6H7N5O3/c7-6(8)10-9-3-4-1-2-5(14-4)11(12)13/h1-3H,(H4,7,8,10)/b9-3+
| Molecular Formula | C6H7N5O3 |
| Molecular Weight | 197.1515 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Furaguanidine (guanofuracin) is a derivative of nitrofuran. It was formerly used as an anti-infective agent, for the treatment of bacillary dysentery, enteritis, and other intestinal infections, and topically to treat skin and mucous membrane infections. The compound was shown to irreversibly inactivate the trypanothione reductase from Trypanosoma cruzi in anaerobic conditions.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:14:48 GMT 2025
by
admin
on
Mon Mar 31 21:14:48 GMT 2025
|
| Record UNII |
1LBX3ODF5I
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1LBX3ODF5I
Created by
admin on Mon Mar 31 21:14:48 GMT 2025 , Edited by admin on Mon Mar 31 21:14:48 GMT 2025
|
PRIMARY | |||
|
100000136932
Created by
admin on Mon Mar 31 21:14:48 GMT 2025 , Edited by admin on Mon Mar 31 21:14:48 GMT 2025
|
PRIMARY | |||
|
DTXSID90184080
Created by
admin on Mon Mar 31 21:14:48 GMT 2025 , Edited by admin on Mon Mar 31 21:14:48 GMT 2025
|
PRIMARY | |||
|
9570079
Created by
admin on Mon Mar 31 21:14:48 GMT 2025 , Edited by admin on Mon Mar 31 21:14:48 GMT 2025
|
PRIMARY | |||
|
300-25-4
Created by
admin on Mon Mar 31 21:14:48 GMT 2025 , Edited by admin on Mon Mar 31 21:14:48 GMT 2025
|
PRIMARY | |||
|
SUB75154
Created by
admin on Mon Mar 31 21:14:48 GMT 2025 , Edited by admin on Mon Mar 31 21:14:48 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |